Propecia is manufactured by a global research driven pharmaceutical company Merck & Company Incorporated, of West Trenton New Jersey. Established in 1891 Merck has been in the forefront of development of vaccines and medicines seeking to address unmet medical needs.

Merck & Co Inc have a needs driven research and development organisation from which came Propecia, which in turn was developed from Proscar, an exciting development in the field of urology, particularly associated with prostate enlargement.

Apart from the Finasteride driven products of Propecia and Proscar, Merck are acknowledged as being in the forefront of vaccine research and development. The medicines and vaccines produced are extensive but include treatments for hepatitis, HIV in combination with antiretroviral agents, combination vaccines for the prevention of childhood ailments etc.

The company is global and their results show continued improvement. Propecia, the medication to treat male hair loss, has shown continued growth with increased sales by as much as 30% year on year, demonstrating the public confidence in the product. Similar results can be seen over the majority of the company’s products.

Merck & Co, in 2004 employed over 62,000 people worldwide and their sales for this period exceeded $22,900 million, which showed an increase of around 24% from 1999. The success of Merck & Co will continue as long as they produce medication with the track record of products like Propecia, the hair loss treatment.